Metformin, a drug for type 2 diabetes, is associated with improved cancer survival.
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Metformin, a drug for type 2 diabetes, is associated with improved cancer survival.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if metformin could be effective in reducing the risk of breast cancer
with or without diabetes with or without obesity with or without hyperinsulinemia any way you slice and dice the data of people with type 2 diabetes with and without metformin they got much less breast cancer which then dogus down a rabbit hole if they seemed to get much less cancer which was you know that was a big aha moment right and there are hundreds of studies that show the association between metformin and less cancers and not only that less all cancer except prostate by the way prostate is hanging there maybe a little bit
the benefits were not subtle in particular the benefits were around a reduction in cancer mortality and survival with cancer as well so both a reduction in the incidence of cancer and an increase in the survival of cancer